The Global Amyotrophic Lateral Sclerosis Drugs Market Size was estimated at USD 308.54 million in 2023 and is projected to reach USD 353.64 million by 2029, exhibiting a CAGR of 2.30% during the forecast period.
The USA market for Global Amyotrophic Lateral Sclerosis Drugs Market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Amyotrophic Lateral Sclerosis Drugs Market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Amyotrophic Lateral Sclerosis Drugs Market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Report Overview:
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrigs disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
The cause is not known in 90% to 95% of cases. The remaining 510% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.
This report provides a deep insight into the global Amyotrophic Lateral Sclerosis Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Amyotrophic Lateral Sclerosis Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Amyotrophic Lateral Sclerosis Drugs market in any manner.
Global Amyotrophic Lateral Sclerosis Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Sanofi
- Mitsubishi Tanabe Pharma
- Mylan
- Apotex
- Glemark Generics
- Sun Pharma
- Covis Pharma
- Lunan Pharma
- CSPC Pharmaceutical
- Ascend Laboratories
- EISAI
Market Segmentation (by Type)
- Riluzole
- Edaravone (Radicava)
- CoQ10
- Butylphthalide
- Others
Market Segmentation (by Application)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Amyotrophic Lateral Sclerosis Drugs Market
- Overview of the regional outlook of the Amyotrophic Lateral Sclerosis Drugs Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Amyotrophic Lateral Sclerosis Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Amyotrophic Lateral Sclerosis Drugs
1.2 Key Market Segments
1.2.1 Amyotrophic Lateral Sclerosis Drugs Segment by Type
1.2.2 Amyotrophic Lateral Sclerosis Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Amyotrophic Lateral Sclerosis Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Amyotrophic Lateral Sclerosis Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Amyotrophic Lateral Sclerosis Drugs Market Competitive Landscape
3.1 Global Amyotrophic Lateral Sclerosis Drugs Sales by Manufacturers (2019-2024)
3.2 Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Amyotrophic Lateral Sclerosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Amyotrophic Lateral Sclerosis Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Amyotrophic Lateral Sclerosis Drugs Sales Sites, Area Served, Product Type
3.6 Amyotrophic Lateral Sclerosis Drugs Market Competitive Situation and Trends
3.6.1 Amyotrophic Lateral Sclerosis Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Amyotrophic Lateral Sclerosis Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Amyotrophic Lateral Sclerosis Drugs Industry Chain Analysis
4.1 Amyotrophic Lateral Sclerosis Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Amyotrophic Lateral Sclerosis Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Amyotrophic Lateral Sclerosis Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Type (2019-2024)
6.3 Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Amyotrophic Lateral Sclerosis Drugs Price by Type (2019-2024)
7 Amyotrophic Lateral Sclerosis Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Amyotrophic Lateral Sclerosis Drugs Market Sales by Application (2019-2024)
7.3 Global Amyotrophic Lateral Sclerosis Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Amyotrophic Lateral Sclerosis Drugs Sales Growth Rate by Application (2019-2024)
8 Amyotrophic Lateral Sclerosis Drugs Market Segmentation by Region
8.1 Global Amyotrophic Lateral Sclerosis Drugs Sales by Region
8.1.1 Global Amyotrophic Lateral Sclerosis Drugs Sales by Region
8.1.2 Global Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Amyotrophic Lateral Sclerosis Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Amyotrophic Lateral Sclerosis Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Amyotrophic Lateral Sclerosis Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Amyotrophic Lateral Sclerosis Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Sanofi
9.1.1 Sanofi Amyotrophic Lateral Sclerosis Drugs Basic Information
9.1.2 Sanofi Amyotrophic Lateral Sclerosis Drugs Product Overview
9.1.3 Sanofi Amyotrophic Lateral Sclerosis Drugs Product Market Performance
9.1.4 Sanofi Business Overview
9.1.5 Sanofi Amyotrophic Lateral Sclerosis Drugs SWOT Analysis
9.1.6 Sanofi Recent Developments
9.2 Mitsubishi Tanabe Pharma
9.2.1 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Basic Information
9.2.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product Overview
9.2.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product Market Performance
9.2.4 Mitsubishi Tanabe Pharma Business Overview
9.2.5 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs SWOT Analysis
9.2.6 Mitsubishi Tanabe Pharma Recent Developments
9.3 Mylan
9.3.1 Mylan Amyotrophic Lateral Sclerosis Drugs Basic Information
9.3.2 Mylan Amyotrophic Lateral Sclerosis Drugs Product Overview
9.3.3 Mylan Amyotrophic Lateral Sclerosis Drugs Product Market Performance
9.3.4 Mylan Amyotrophic Lateral Sclerosis Drugs SWOT Analysis
9.3.5 Mylan Business Overview
9.3.6 Mylan Recent Developments
9.4 Apotex
9.4.1 Apotex Amyotrophic Lateral Sclerosis Drugs Basic Information
9.4.2 Apotex Amyotrophic Lateral Sclerosis Drugs Product Overview
9.4.3 Apotex Amyotrophic Lateral Sclerosis Drugs Product Market Performance
9.4.4 Apotex Business Overview
9.4.5 Apotex Recent Developments
9.5 Glemark Generics
9.5.1 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Basic Information
9.5.2 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product Overview
9.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product Market Performance
9.5.4 Glemark Generics Business Overview
9.5.5 Glemark Generics Recent Developments
9.6 Sun Pharma
9.6.1 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Basic Information
9.6.2 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product Overview
9.6.3 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product Market Performance
9.6.4 Sun Pharma Business Overview
9.6.5 Sun Pharma Recent Developments
9.7 Covis Pharma
9.7.1 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Basic Information
9.7.2 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product Overview
9.7.3 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product Market Performance
9.7.4 Covis Pharma Business Overview
9.7.5 Covis Pharma Recent Developments
9.8 Lunan Pharma
9.8.1 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Basic Information
9.8.2 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Product Overview
9.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Product Market Performance
9.8.4 Lunan Pharma Business Overview
9.8.5 Lunan Pharma Recent Developments
9.9 CSPC Pharmaceutical
9.9.1 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Basic Information
9.9.2 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product Overview
9.9.3 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product Market Performance
9.9.4 CSPC Pharmaceutical Business Overview
9.9.5 CSPC Pharmaceutical Recent Developments
9.10 Ascend Laboratories
9.10.1 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Basic Information
9.10.2 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product Overview
9.10.3 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product Market Performance
9.10.4 Ascend Laboratories Business Overview
9.10.5 Ascend Laboratories Recent Developments
9.11 EISAI
9.11.1 EISAI Amyotrophic Lateral Sclerosis Drugs Basic Information
9.11.2 EISAI Amyotrophic Lateral Sclerosis Drugs Product Overview
9.11.3 EISAI Amyotrophic Lateral Sclerosis Drugs Product Market Performance
9.11.4 EISAI Business Overview
9.11.5 EISAI Recent Developments
10 Amyotrophic Lateral Sclerosis Drugs Market Forecast by Region
10.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size Forecast
10.2 Global Amyotrophic Lateral Sclerosis Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Region
10.2.4 South America Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Amyotrophic Lateral Sclerosis Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Amyotrophic Lateral Sclerosis Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Amyotrophic Lateral Sclerosis Drugs by Type (2025-2030)
11.1.2 Global Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Amyotrophic Lateral Sclerosis Drugs by Type (2025-2030)
11.2 Global Amyotrophic Lateral Sclerosis Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Amyotrophic Lateral Sclerosis Drugs Sales (K Units) Forecast by Application
11.2.2 Global Amyotrophic Lateral Sclerosis Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Amyotrophic Lateral Sclerosis Drugs Market Size Comparison by Region (M USD)
Table 5. Global Amyotrophic Lateral Sclerosis Drugs Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Amyotrophic Lateral Sclerosis Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Drugs as of 2022)
Table 10. Global Market Amyotrophic Lateral Sclerosis Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Amyotrophic Lateral Sclerosis Drugs Sales Sites and Area Served
Table 12. Manufacturers Amyotrophic Lateral Sclerosis Drugs Product Type
Table 13. Global Amyotrophic Lateral Sclerosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Amyotrophic Lateral Sclerosis Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Amyotrophic Lateral Sclerosis Drugs Market Challenges
Table 22. Global Amyotrophic Lateral Sclerosis Drugs Sales by Type (K Units)
Table 23. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Type (M USD)
Table 24. Global Amyotrophic Lateral Sclerosis Drugs Sales (K Units) by Type (2019-2024)
Table 25. Global Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Amyotrophic Lateral Sclerosis Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Amyotrophic Lateral Sclerosis Drugs Market Size Share by Type (2019-2024)
Table 28. Global Amyotrophic Lateral Sclerosis Drugs Price (USD/Unit) by Type (2019-2024)
Table 29. Global Amyotrophic Lateral Sclerosis Drugs Sales (K Units) by Application
Table 30. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application
Table 31. Global Amyotrophic Lateral Sclerosis Drugs Sales by Application (2019-2024) & (K Units)
Table 32. Global Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Amyotrophic Lateral Sclerosis Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2019-2024)
Table 35. Global Amyotrophic Lateral Sclerosis Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Amyotrophic Lateral Sclerosis Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Global Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Amyotrophic Lateral Sclerosis Drugs Sales by Country (2019-2024) & (K Units)
Table 39. Europe Amyotrophic Lateral Sclerosis Drugs Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Amyotrophic Lateral Sclerosis Drugs Sales by Region (2019-2024) & (K Units)
Table 41. South America Amyotrophic Lateral Sclerosis Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Sales by Region (2019-2024) & (K Units)
Table 43. Sanofi Amyotrophic Lateral Sclerosis Drugs Basic Information
Table 44. Sanofi Amyotrophic Lateral Sclerosis Drugs Product Overview
Table 45. Sanofi Amyotrophic Lateral Sclerosis Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Sanofi Business Overview
Table 47. Sanofi Amyotrophic Lateral Sclerosis Drugs SWOT Analysis
Table 48. Sanofi Recent Developments
Table 49. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Basic Information
Table 50. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product Overview
Table 51. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Mitsubishi Tanabe Pharma Business Overview
Table 53. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs SWOT Analysis
Table 54. Mitsubishi Tanabe Pharma Recent Developments
Table 55. Mylan Amyotrophic Lateral Sclerosis Drugs Basic Information
Table 56. Mylan Amyotrophic Lateral Sclerosis Drugs Product Overview
Table 57. Mylan Amyotrophic Lateral Sclerosis Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Mylan Amyotrophic Lateral Sclerosis Drugs SWOT Analysis
Table 59. Mylan Business Overview
Table 60. Mylan Recent Developments
Table 61. Apotex Amyotrophic Lateral Sclerosis Drugs Basic Information
Table 62. Apotex Amyotrophic Lateral Sclerosis Drugs Product Overview
Table 63. Apotex Amyotrophic Lateral Sclerosis Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Apotex Business Overview
Table 65. Apotex Recent Developments
Table 66. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Basic Information
Table 67. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product Overview
Table 68. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Glemark Generics Business Overview
Table 70. Glemark Generics Recent Developments
Table 71. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Basic Information
Table 72. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product Overview
Table 73. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Sun Pharma Business Overview
Table 75. Sun Pharma Recent Developments
Table 76. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Basic Information
Table 77. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product Overview
Table 78. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Covis Pharma Business Overview
Table 80. Covis Pharma Recent Developments
Table 81. Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Basic Information
Table 82. Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Product Overview
Table 83. Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Lunan Pharma Business Overview
Table 85. Lunan Pharma Recent Developments
Table 86. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Basic Information
Table 87. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product Overview
Table 88. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. CSPC Pharmaceutical Business Overview
Table 90. CSPC Pharmaceutical Recent Developments
Table 91. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Basic Information
Table 92. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product Overview
Table 93. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Ascend Laboratories Business Overview
Table 95. Ascend Laboratories Recent Developments
Table 96. EISAI Amyotrophic Lateral Sclerosis Drugs Basic Information
Table 97. EISAI Amyotrophic Lateral Sclerosis Drugs Product Overview
Table 98. EISAI Amyotrophic Lateral Sclerosis Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. EISAI Business Overview
Table 100. EISAI Recent Developments
Table 101. Global Amyotrophic Lateral Sclerosis Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Amyotrophic Lateral Sclerosis Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Amyotrophic Lateral Sclerosis Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Amyotrophic Lateral Sclerosis Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Amyotrophic Lateral Sclerosis Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Amyotrophic Lateral Sclerosis Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Amyotrophic Lateral Sclerosis Drugs Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Amyotrophic Lateral Sclerosis Drugs Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Amyotrophic Lateral Sclerosis Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Amyotrophic Lateral Sclerosis Drugs Market Size (M USD), 2019-2030
Figure 5. Global Amyotrophic Lateral Sclerosis Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Amyotrophic Lateral Sclerosis Drugs Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Amyotrophic Lateral Sclerosis Drugs Market Size by Country (M USD)
Figure 11. Amyotrophic Lateral Sclerosis Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Manufacturers in 2023
Figure 13. Amyotrophic Lateral Sclerosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Amyotrophic Lateral Sclerosis Drugs Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Amyotrophic Lateral Sclerosis Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Type
Figure 18. Sales Market Share of Amyotrophic Lateral Sclerosis Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Amyotrophic Lateral Sclerosis Drugs by Type in 2023
Figure 20. Market Size Share of Amyotrophic Lateral Sclerosis Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Amyotrophic Lateral Sclerosis Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application
Figure 24. Global Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Application in 2023
Figure 26. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2019-2024)
Figure 27. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application in 2023
Figure 28. Global Amyotrophic Lateral Sclerosis Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Amyotrophic Lateral Sclerosis Drugs Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Amyotrophic Lateral Sclerosis Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Country in 2023
Figure 37. Germany Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Region in 2023
Figure 44. China Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (K Units)
Figure 50. South America Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Amyotrophic Lateral Sclerosis Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Amyotrophic Lateral Sclerosis Drugs Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Amyotrophic Lateral Sclerosis Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Amyotrophic Lateral Sclerosis Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Amyotrophic Lateral Sclerosis Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Amyotrophic Lateral Sclerosis Drugs Market Share Forecast by Application (2025-2030)
